Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT - Cellular Biomedicine Group, Inc. | cbmg_10q.htm |
| EX-99.2 - AGREEMENT OF CLINICAL TEST - Cellular Biomedicine Group, Inc. | ex_992.htm |
| EX-99.1 - CONSULTING AGREEMENT - Cellular Biomedicine Group, Inc. | ex_991.htm |
| EX-31.1 - CERTIFICATION - Cellular Biomedicine Group, Inc. | cbmg_ex311.htm |
Exhibit 32.1
CERTIFICATION
In connection with the periodic report of Cellular Biomedicine Group, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2016 as filed with the Securities and Exchange Commission (the “Report”), I, Bizuo (Tony) Liu, Chief Executive Officer and Chief Financial Officer (Principal Executive Officer and Principal Financial and Accounting Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of our knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.
|
Date: May 9, 2016
|
By:
|
/s/ Bizuo (Tony) Liu
|
|
|
Bizuo (Tony) Liu
|
|||
|
Chief Executive Officer, Chief Financial Officer and Secretary
|
|||
|
(Principal Executive Officer and Principal Financial and Accounting Officer)
|
|||